Clinical Trials Browser

Phase 1/2 × Melanoma × Injections × Clear all

Melanoma, Ovarian Neoplasms, Lymphoma, T-Cell

NCT06209580 2025-09-05

AMT-253 in Patients With Advanced Solid Tumours

Phase 1/2 Recruiting

96 enrolled

Dermatologic

Melanoma

NCT00041808 2005-06-24

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Phase 1/2 Completed

20 enrolled

BreastDermatologicGastrointestinalSarcomaThoracic

Breast Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

Clinical Trials

MK-3475-D20

AMT-253 in Patients With Advanced Solid Tumours

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver